Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Irinotecan
×
1 year
×
Clear all
Filters
3
NCT05239741
2026-03-10
MK-3475-C66
Merck Sharp & Dohme LLC
Phase 3
Recruiting
100 enrolled
NCT05319730
2026-03-02
MK-3475-06B
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
230 enrolled